|
|
|
Investigators
|
|
Faculty › Investigators
|
Lennart Mucke, M.D.
Director
Gladstone Institute of Neurological Disease
Joseph B. Martin Distinguished Professor of Neuroscience
University of California, San Francisco
Interests/Approaches: Alzheimer's disease, amyloid
proteins, mechanisms of neurodegeneration, cognitive functions and
their disruption by disease, glia, preclinical assessment of novel
therapeutic strategies, transgenic models.
|
|
Katerina Akassoglou, Ph.D.
Associate Investigator
Gladstone Institute of Neurological Disease
Associate Professor of Neurology
University of California, San Francisco
Interests/Approaches: Neurovascular communication,
Multiple Sclerosis, BBB disruption, fibrinogen, inflammation,
microglia, in vivo multiphoton imaging, p75 neurotrophin receptor
signaling and functions, extracellular matrix, tissue repair
|
|
Steven M. Finkbeiner, M.D., Ph.D.
Associate Director and Senior Investigator
Gladstone Institute of Neurological Disease
Professor of Neurology and Physiology
University of California, San Francisco
Interests/Approaches: astroglial-neuronal communication,
calcium imaging, confocal microscopy, Huntington's disease, gene gun,
neuroplasticity, neurotrophins, organotypic cultures,
trinucleotide-repeat diseases.
|
|
Li Gan, Ph.D.
Associate Investigator
Gladstone Institute of Neurological Disease
Assistant Professor of Neurology
University of California, San Francisco
Interests/Approaches: Alzheimer's disease,
microglial-neuronal interaction, RNA interference, gene silencing,
viral vector-mediated gene transfer, neurodegeneration, transgenic
models, preclinical validation of novel therapeutic targets
|
|
Yadong Huang, M.D., Ph.D.
Associate Investigator
Gladstone Institute of Neurological Disease
Associate Professor of Pathology and Neurology
University of California, San Francisco
Interests/Approaches: Alzheimer's disease, apoE, brain
lipid metabolism, cytoskeletal structure and function,
neurodegeneration, proteases, protease inhibitors, tau protein,
transgenic models.
|
|
Anatol Kreitzer, Ph.D.
Assistant Investigator
Gladstone Institute of Neurological Disease
Assistant Professor of Physiology and Neurology
University of California, San Francisco
Interests/Approaches: Basal ganglia, dopamine,
electrophysiology, endocannabinoids, Huntington's disease, movement
disorders, neural circuits and behavior, optical imaging, Parkinson's
disease, striatum, synaptic plasticity.
|
|
Robert W. Mahley, M.D., Ph.D.
President Emeritus, The J. David Gladstone Institutes
Senior Investigator, Gladstone Institute of Neurological Disease
Professor of Pathology and Medicine
University of California, San Francisco
Interests/Approaches: Alzheimer's disease, apoE, cell
biology, cytoskeleton, DNA chips, lipid transport, proteoglycans.
|
|
Paul Muchowski, Ph.D.
Associate Investigator
Gladstone Institute of Neurological Disease
Associate Professor of Biochemistry, Biophysics, and Neurology
University of California, San Francisco
Interests/Approaches: Protein misfolding, mechanisms of
neurodegeneration, yeast genetic and chemical-genetic screens, atomic
force microscopy, chaperone proteins.
|
 |
Ken Nakamura, M.D., Ph.D.
Assistant Investigator
Gladstone Institute of Neurological Disease
Assistant Professor of Neurology
University of California, San Francisco
Interests/Approaches: Mitochondria, Parkinson's disease, dopamine, Alzheimer's disease, mechanisms of neurodegeneration, movement disorders, cell biology, neuronal cultures, optical imaging, purified proteins, transgenic models. |
|
Jorge J. Palop, Ph.D.
Staff Research
Investigator
Gladstone Institute of Neurological Disease
Assistant Professor of Neurology
University of California, San Francisco
Interests/Approaches: Alzheimer's disease, amyloid beta,
mechanisms of amyloid beta-induced cognitive deficits and network
dysfunction, epileptiform activity and seizures, hippocampal
remodeling, transgenic models of Alzheimer's disease, behavior, EEG
recordings, physiology, pharmacology, genetic manipulations.
|
|
|
|
|
|
|